author-photo

Alnoor Ramji

University of British Columbia

119

Papers

4282

Citations

Citation Trend

Filter By

Papers (82) Sort By

Journal Conference Others

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)

2021
Show All
- Source
- Cite
- Save
Citations (0)
IDDF2021-ABS-0080 96-week efficacy and safety of tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switch vs. continued TDF treatment among virologically-suppressed hepatitis B patients of asian ethnicity

2021 Gut
Show All
- Source
- Cite
- Save
Citations (0)
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD).

2021
Show All
- Source
- Cite
- Save
Citations (5)
A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians

2021
Show All
- Source
- Cite
- Save
Citations (0)
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: a CANUHC analysis

2021
Show All
- Source
- Cite
- Save
Citations (0)
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.

2020
Show All
- Source
- Cite
- Save
Citations (13)
Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection

2020
Show All
- Source
- Cite
- Save
Citations (5)
Time from diagnosis to treatment in vulnerable populations versus general population: Do we testand-treat our HCV patients in the same way?

2020 Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
Distinct Hepatitis B and HIV co-infected populations in Canada

2020 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (1)
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

2020 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (37)